Status:
COMPLETED
COVID19-FOIE National Observatory
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Association Française pour l'Etude du Foie (AFEF)
Conditions:
Liver Diseases
COVID19
Eligibility:
All Genders
18-80 years
Brief Summary
Background: The COVID19 and liver relationships are very rare. The preliminary Chinese data indicate that 2-11% of patients treated for COVID19 had an underlying chronic liver disease. However, there...
Detailed Description
1. Background and objectives: Coronavirus infection 2019 (COVID-19), linked to the SARS-Cov-2 virus, is rapidly spreading worldwide. After the city of Wuhan and the province of Hubei, European hea...
Eligibility Criteria
Inclusion
- All patients with acute or chronic liver disease managed by a member of AFEF with positive diagnosis of COVID-19 by PCR and/or specific abnormalities at the thoracic TDM
- Patients with history of liver transplantation
- Patients affiliated with social security
Exclusion
- Age inferior to 18 years
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
1132 Patients enrolled
Trial Details
Trial ID
NCT04375670
Start Date
May 11 2020
End Date
May 31 2022
Last Update
August 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ganne
Bondy, France, 93140